Abstract
Researchers are using pathway information for both pharmacogenomics study design and data analysis. Candidate gene approaches for the design of pharmacogenomic studies need reliable pathway information to choose the best candidate genes and SNPs, especially when using low to medium throughput genotyping technologies, to maximize the likelihood of success. With the mainstream use of high throughput gene expression microarrays and genome wide SNP assays, pathway-based approaches can also be valuable tool for data analysis. This review will discuss sources of pathway data and mechanisms for applying it to pharmacogenomics research.
Keywords: HumanCyc pathway, STKE Connections, CYP gene, GenMAPP, Systems Biology Mark-Up Language
Current Pharmacogenomics
Title: Pathway-based Approaches to Pharmacogenomics
Volume: 5 Issue: 1
Author(s): C. F. Thorn, M. Whirl-Carrillo, T. E. Klein and R. B. Altman
Affiliation:
Keywords: HumanCyc pathway, STKE Connections, CYP gene, GenMAPP, Systems Biology Mark-Up Language
Abstract: Researchers are using pathway information for both pharmacogenomics study design and data analysis. Candidate gene approaches for the design of pharmacogenomic studies need reliable pathway information to choose the best candidate genes and SNPs, especially when using low to medium throughput genotyping technologies, to maximize the likelihood of success. With the mainstream use of high throughput gene expression microarrays and genome wide SNP assays, pathway-based approaches can also be valuable tool for data analysis. This review will discuss sources of pathway data and mechanisms for applying it to pharmacogenomics research.
Export Options
About this article
Cite this article as:
Thorn F. C., Whirl-Carrillo M., Klein E. T. and Altman B. R., Pathway-based Approaches to Pharmacogenomics, Current Pharmacogenomics 2007; 5 (1) . https://dx.doi.org/10.2174/157016007780077167
DOI https://dx.doi.org/10.2174/157016007780077167 |
Print ISSN 1570-1603 |
Publisher Name Bentham Science Publisher |
Online ISSN 1570-1603 |
Related Articles
-
Editorial: Looking Forward to Another Successful Year
Current Cancer Drug Targets Editorial (Thematic Issue: Targeted Therapies in Upper Gastrointestinal Malignancies)
Current Medicinal Chemistry From Chemical Graphs in Computer-Aided Drug Design to General Markov-Galvez Indices of Drug-Target, Proteome, Drug-Parasitic Disease, Technological, and Social-Legal Networks
Current Computer-Aided Drug Design The Histone Deacetylase SIRT6: At the Crossroads Between Epigenetics, Metabolism and Disease
Current Topics in Medicinal Chemistry Radioimmunotherapy of Cancer Using Monoclonal Antibodies to Target Radiotherapy
Current Pharmaceutical Design Autoimmunity and Apoptosis - Therapeutic Implications
Current Medicinal Chemistry Major Highlights of the CAR-TCR Summit, Boston, 2016
Anti-Cancer Agents in Medicinal Chemistry Rapid Screening of Antioxidant Active Constituents from Puerariae Lobatae Radix Based on the Investigation of Quantitative Patteren-Activity Relationship
Current Analytical Chemistry Applications of Nanosystems to Anticancer Drug Therapy (Part II. Dendrimers, Micelles, Lipid-based Nanosystems)
Recent Patents on Anti-Cancer Drug Discovery Tribulus arabicus and Tribulus macropterus are Comparable to Tribulus terrestris: An Antioxidant Assessment
Current Bioactive Compounds Meet Our Associate Editorial Board Member
Current Pharmaceutical Biotechnology Patent Selections:
Current Biomarkers (Discontinued) Reproductive Toxicology of Environmental Toxicants: Emerging Issues and Concerns
Current Pharmaceutical Design Improved Immunotoxins with Novel Functional Elements
Current Pharmaceutical Design Editorial (Thematic Issue: Emerging Immunotargets in Genitourinary Tumors)
Current Drug Targets Novel Marine and Microbial Natural Product Inhibitors of Vacuolar ATPase
Current Medicinal Chemistry Protein-protein Interactions: Network Analysis and Applications in Drug Discovery
Current Pharmaceutical Design Phosphonium Salt Displays Cytotoxic Effects Against Human Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Primary Management of Metastatic Colorectal Cancer with Bevacizumab. Review Article Focusing on Efficacy
Current Cancer Therapy Reviews Specific Targets in Tumor Tissue for the Delivery of Therapeutic Genes
Current Medicinal Chemistry - Anti-Cancer Agents